Genprex Inc GNPX
NASDAQ · United States · Health Technology
$2.56-0.36 (-12.33%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise |
|---|---|---|---|---|
| Q1 2025 | 2025-05-12 | -286.00 | -451.00 | +36.6% |
| Q4 2024 | 2025-04-01 | 2.58 | -0.39 | +761.5% |
| Q3 2024 | 2024-11-13 | -1,353.00 | -3,003.00 | +54.9% |
| Q2 2024 | 2024-08-09 | -3,300.00 | -2,530.00 | -30.4% |
| Q1 2024 | 2024-05-15 | -4,059.00 | -2,794.00 | -45.3% |
| Q4 2023 | 2024-04-01 | -24,299.02 | -6,044.51 | -302.0% |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.